Vir Biotechnology, Inc. (VIR)
6.69
+0.06
(+0.90%)
USD |
NASDAQ |
Dec 12, 16:00
6.73
+0.04
(+0.60%)
After-Hours: 20:00
Vir Biotechnology EPS Diluted (Quarterly): -1.174 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.5432 |
| Bristol Myers Squibb Co. | 1.079 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -163.14M |
| Revenue (Quarterly) | 0.24M |
| Total Expenses (Quarterly) | 163.38M |
| Enterprise Value | 522.19M |
| Gross Profit Margin (Quarterly) | -1.14K% |
| Profit Margin (Quarterly) | -67.98K% |
| Earnings Yield | -54.11% |
| Normalized Earnings Yield | -52.15 |